Experience

Debiopharm

• Switzerland
• Pharmaceutical Manufacturing
• 300 - 400 Employee

• Senior Scientist

  • Jun 2022 - Present

  Lead microbiologist on each of the anti-infective programs spanning pre-clinical to phase II development Lead microbiologist on each of the anti-infective programs spanning pre-clinical to phase II development



Insel Gruppe

• Switzerland
• Hospitals and Health Care
• 700 & Above Employee

• Scientific Researcher

  • Aug 2018 - May 2022

  Investigated the potential for bacteriophages to treat infections due to multidrug-resistant bacteria - Principal investigator on competitively funded research projects - Managed the laboratory team (one PhD student, two research technicians) - Desiged and executed animal models that mimic human infections for the assessment of novel anti-infective therapies (i.e. bacteriophages, antibiotic-bacteriophage combinations, monoclonal anti toxin antibodies) - Discovered new anti-infectives from within the human skin microbiome - Participated in clinical trials - Analysed and communicated data; wrote publications - Established and maintained collaborations within industry and academia



Antimicrobial Discovery Center, Northeastern University

• Boston

• Postdoctoral Research Fellow, Kim Lewis Lab

  • Jan 2016 - Jul 2018

  - Used genome-wide screening approaches to identify a metabolic gene that underpins multidrug antibiotic tolerance - Performed high-throughput screening of >500 clinical isolates of multidrug resistant bacteria for antibiotic tolerance phenotypes - Analysed large datasets - Lectured the first level Microbiology course to undergraduate students - Used genome-wide screening approaches to identify a metabolic gene that underpins multidrug antibiotic tolerance - Performed high-throughput screening of >500 clinical isolates of multidrug resistant bacteria for antibiotic tolerance phenotypes - Analysed large datasets - Lectured the first level Microbiology course to undergraduate students



Monash University

• Australia
• Higher Education
• 700 & Above Employee

• Postdoctoral Researcher

  • Aug 2014 - Dec 2015

  - Used animal models of bacteraemia to define a relationship between antibiotic resistance and pathogenesis for MRSA - Used multidisciplinary approaches to define mechanisms of antibiotic resistance for the last line anti-staphylococcals vancomycin, daptomycin and linezolid - Used animal models of bacteraemia to define a relationship between antibiotic resistance and pathogenesis for MRSA - Used multidisciplinary approaches to define mechanisms of antibiotic resistance for the last line anti-staphylococcals vancomycin, daptomycin and linezolid



Gippsland Pathology Service

• Victoria, Australia

• Medical Scientist

  • Jan 2009 - Dec 2009